MedTrace Logo

Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer

NCT01419002 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2015-07-29

No results posted yet for this study

Summary

Net-Pac investigates if radiation prior to surgical resection improves survival in patients with pancreatic head cancer without metastases.

Conditions

  • Pancreatic Adenocarcinoma

Interventions

RADIATION

neoadjuvant RTx

Neoadjuvant radiotherapy with external intensity modulated beam radiation followed by duodenopancreatectomy and adjuvant chemotherapy according to German S3 guidelines.

PROCEDURE

Surgery

Surgery and adjuvant chemotherapy according to German S3-guidelines

Sponsors & Collaborators

  • Technical University of Munich

    collaborator OTHER

  • CHIR-Net

    lead NETWORK

Principal Investigators

  • Helmut M Friess, Prof. MD · Technical University of Munich

  • Michael Molls, Prof. MD · Technical University of Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419002 on ClinicalTrials.gov